Document is current
Any future updates will be listed below
-
Authors
Vallon, Volker https://orcid.org/0000-0002-9211-2063
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK112042)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK106102)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079337)
National Heart, Lung, and Blood Institute (R01HL142814)
National Institute on Aging (RF1AG061296)
- License Information
-
More Information
Article History
Received: 31 December 2019
Revised: 18 February 2020
Accepted: 20 February 2020
First Online: 6 March 2020
Compliance with ethical standards
:
: Over the past 36 months, VV has served as a consultant and received honoraria from Astra-Zeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Janssen Pharmaceutical, Merck, and Retrophin, and received grant support for investigator-initiated research from Astra-Zeneca, Bayer, Boehringer Ingelheim, Fresenius, Janssen, and Novo-Nordisk.
